MNT-002

N/A

Report date: 2024/04/28 18:06:23

Base Information

Drug NameMNT-002
Drug Alias NameMNT-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 inhibitors
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMinotaur Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMinotaur Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A